TMO | Thermo Fisher Scientific, Inc. | $258.7b | $689.72 | -0.3% | 382.1K |
A | Agilent Technologies Inc. | $49.5b | $171.78 | -0.7% | 259.3K |
WAT | Waters Corp | $45.2b | $450.01 | -0.7% | 118.3K |
IQV | IQVIA Holdings Inc. | $43.3b | $259.00 | -2.3% | 461.3K |
RPRX | Royalty Pharma plc Class A Ordinary Shares | $29.6b | $67.94 | -0.9% | 733.9K |
WST | West Pharmaceutical Services, Inc. | $28.4b | $414.85 | -0.8% | 94.8K |
MEDP | Medpace Holdings, Inc. Common Stock | $18.6b | $647.94 | -0.7% | 42.8K |
RVTY | Revvity, Inc. | $18.2b | $149.36 | +0.5% | 288.0K |
CRL | Charles River Laboratories International, Inc. | $16.8b | $335.73 | -0.0% | 195.7K |
ASND | Ascendis Pharma A/S Ordinary Share | $16.5b | $264.88 | -2.8% | 201.5K |
ICLR | Icon Plc | $15.3b | $194.09 | +1.6% | 176.5K |
HALO | Halozyme Therapeutics, Inc. | $14.6b | $95.50 | -1.0% | 507.0K |
TECH | Bio-Techne Corp. | $11.4b | $72.75 | -0.1% | 1.7M |
RGEN | Repligen Corp | $11.3b | $161.01 | -1.1% | 139.5K |
KYMR | Kymera Therapeutics, Inc. Common Stock | $10.8b | $120.15 | -4.4% | 196.6K |
AVTR | Avantor, Inc. | $10.6b | $15.29 | -0.4% | 1.4M |
QGEN | QIAGEN N.V. | $10.4b | $49.81 | +0.0% | 964.1K |
TWST | Twist Bioscience Corporation Common Stock | $9.3b | $105.19 | -0.1% | 435.3K |
BRKR | Bruker Corporation | $8.6b | $60.86 | +0.3% | 450.6K |
LGND | Ligand Pharmaceuticals Inc. | $6.3b | $297.51 | -1.4% | 96.2K |
KOD | Kodiak Sciences Inc Common Stock | $6.2b | $96.15 | -5.0% | 213.3K |
CGON | CG Oncology, Inc. Common stock | $5.7b | $76.25 | -9.3% | 1.3M |
MANE | Veradermics, Incorporated | $5.6b | $125.06 | -1.9% | 175.5K |
ABCL | AbCellera Biologics Inc. Common Shares | $3.9b | $10.97 | -1.3% | 1.0M |
RLAY | Relay Therapeutics, Inc. Common Stock | $3.8b | $16.77 | -2.9% | 590.5K |
OGN | Organon & Co. | $3.6b | $13.89 | -0.0% | 720.0K |
CELC | Celcuity Inc. Common Stock | $3.4b | $57.73 | -4.1% | 401.3K |
NRIX | Nurix Therapeutics, Inc. Common stock | $2.8b | $14.23 | -3.7% | 489.7K |
DAWN | Day One Biopharmaceuticals, Inc. Common Stock | $2.2b | $21.52 | -0.0% | 3.0M |
RXRX | Recursion Pharmaceuticals, Inc. Class A Common Stock | $2.2b | $2.75 | -4.3% | 7.8M |
ZYME | Zymeworks Inc. | $2.2b | $25.67 | -2.9% | 94.2K |
SDGR | Schrodinger, Inc. Common Stock | $2.0b | $26.07 | -4.5% | 487.4K |
FTRE | Fortrea Holdings Inc. Common Stock | $2.0b | $19.90 | +0.5% | 833.5K |
TRVI | Trevi Therapeutics, Inc. Common Stock | $2.0b | $13.09 | -1.5% | 438.4K |
SLS | SELLAS Life Sciences Group, Inc. Common Stock | $1.8b | $20.32 | +170.7% | 82.7M |
GENB | Generate Biomedicines, Inc. Common Stock | $1.8b | $9.77 | -6.7% | 318.8K |
ABSI | Absci Corporation Common Stock | $1.7b | $7.44 | +0.3% | 2.3M |
CERT | Certara, Inc. Common Stock | $1.7b | $11.34 | -0.5% | 353.8K |
ALVO | Alvotech Ordinary Shares | $1.6b | $4.45 | +0.9% | 523.0K |
TYRA | Tyra Biosciences, Inc. Common Stock | $1.5b | $19.79 | +2.5% | 259.3K |
PCRX | Pacira BioSciences, Inc. Common Stock | $1.5b | $36.48 | 0.0% | N/A |
OPK | Opko Health Inc. | $1.3b | $1.60 | -0.9% | 770.8K |
VOR | Vor Biopharma Inc. Common Stock | $1.2b | $18.06 | -3.9% | 303.5K |
INBX | Inhibrx Biosciences, Inc. Common Stock | $1.2b | $73.45 | -4.7% | 56.6K |
MRVI | Maravai LifeSciences Holdings, Inc. Class A Common Stock | $1.1b | $7.22 | -2.2% | 235.9K |
HROW | Harrow, Inc. Common Stock | $1.1b | $29.38 | +1.4% | 139.4K |
GLUE | Monte Rosa Therapeutics, Inc. Common Stock | $0.9b | $8.87 | -2.5% | 310.1K |
OABI | OmniAb, Inc. Common Stock | $0.8b | $4.87 | -0.8% | 410.1K |
XOMA | XOMA Royalty Corporation Common Stock | $0.7b | $39.35 | 0.0% | N/A |
SANA | Sana Biotechnology, Inc. Common Stock | $0.7b | $1.86 | -0.3% | 883.7K |